Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer
Authors
Keywords
-
Journal
Molecular Oncology
Volume 10, Issue 2, Pages 213-223
Publisher
Wiley
Online
2015-10-10
DOI
10.1016/j.molonc.2015.09.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA damage response – A double-edged sword in cancer prevention and cancer therapy
- (2015) Hui Tian et al. CANCER LETTERS
- Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer
- (2015) A. Arora et al. MOLECULAR CANCER THERAPEUTICS
- Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
- (2014) Christopher Bryant et al. BMC CANCER
- ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses
- (2014) R. Josse et al. CANCER RESEARCH
- Quality control of homologous recombination
- (2014) Ting Liu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Structural insights into NHEJ: Building up an integrated picture of the dynamic DSB repair super complex, one component and interaction at a time
- (2014) Gareth J. Williams et al. DNA REPAIR
- The DNA damage response: The omics era and its impact
- (2014) Kasper W.J. Derks et al. DNA REPAIR
- Base excision repair: A critical player in many games
- (2014) Susan S. Wallace DNA REPAIR
- Radiosensitization of Human Leukemic HL-60 Cells by ATR Kinase Inhibitor (VE-821): Phosphoproteomic Analysis
- (2014) Barbora Šalovská et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer
- (2014) Tarek M.A. Abdel-Fatah et al. Molecular Oncology
- Development of pharmacodynamic biomarkers for ATR inhibitors
- (2014) Tao Chen et al. Molecular Oncology
- Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
- (2014) Nada Albarakati et al. Molecular Oncology
- Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts
- (2014) Tarek M.A. Abdel-Fatah et al. NEOPLASIA
- DNA Double Strand Break Repair: A Radiation Perspective
- (2013) Joy N. Kavanagh et al. ANTIOXIDANTS & REDOX SIGNALING
- Ionizing Radiation-Induced DNA Damage, Response, and Repair
- (2013) Wil L. Santivasi et al. ANTIOXIDANTS & REDOX SIGNALING
- p53 in breast cancer subtypes and new insights into response to chemotherapy
- (2013) Philippe Bertheau et al. BREAST
- Targeting ATR in DNA damage response and cancer therapeutics
- (2013) Emmanouil Fokas et al. CANCER TREATMENT REVIEWS
- Roles of Chk1 in cell biology and cancer therapy
- (2013) Youwei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL-60)
- (2013) Jiřina Vávrová et al. RADIATION AND ENVIRONMENTAL BIOPHYSICS
- DNA Damage Sensing by the ATM and ATR Kinases
- (2013) A. Marechal et al. Cold Spring Harbor Perspectives in Biology
- Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: A meta-analysis
- (2012) M. Gieni et al. BREAST
- Coupling Cellular Localization and Function of Checkpoint Kinase 1 (Chk1) in Checkpoints and Cell Viability
- (2012) Jingna Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivo
- (2012) ZHIKUN MA et al. Molecular Medicine Reports
- Chk1 knockdown confers radiosensitization in prostate cancer stem cells
- (2012) XIAOBIN WANG et al. ONCOLOGY REPORTS
- Predictive Factors for Local Recurrence in Breast Cancer
- (2012) Femke van der Leij et al. SEMINARS IN RADIATION ONCOLOGY
- ATR signalling: more than meeting at the fork
- (2011) Edward A. Nam et al. BIOCHEMICAL JOURNAL
- Chk1 inhibitor Gö6976 enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy and chemotherapy in vitro and in vivo
- (2010) Zizhen Feng et al. CANCER LETTERS
- Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2Checkpoint and Inhibition of Homologous Recombinational DNA Repair
- (2010) Meredith A. Morgan et al. CANCER RESEARCH
- Mechanisms of ATR-mediated checkpoint signalling
- (2010) Veronique et al. Frontiers in Bioscience-Landmark
- Expanded Roles for Chk1 in Genome Maintenance
- (2008) Greg H. Enders JOURNAL OF BIOLOGICAL CHEMISTRY
- ATR: an essential regulator of genome integrity
- (2008) Karlene A. Cimprich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now